Stock Updates

A look at a High Market Cap Stock: Zimmer Biomet Holdings, Inc., ZBH

Zimmer Biomet Holdings, Inc., ZBH is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Zimmer Biomet Holdings, Inc., ZBH  has a market cap of 24148.07. Since its IPO date on the *TBA, Zimmer Biomet Holdings, Inc., ZBH performance year to date is 18.14%. Today Zimmer Biomet Holdings, Inc., ZBH has gained -0.75%, with a current price of 119.77.

Ownership of the company is 0.20% for insider ownership while institutional ownership is 93.70%. The management of the company have seen the company have a payout ratio of *TBA. Return of assets are at *TBA, with return on investment at 2.10%.

In terms of debt levels and profit levels, Zimmer Biomet Holdings, Inc., ZBH is seeing a long-term debt/equity of 1.15. While Total debt/equity is 0. With a profit margin of *TBA, this is combined with a gross margin of 69.60%, and operating margin of *TBA. Zimmer Biomet Holdings, Inc. ability to meet debt levels, with a current ratio of 3.4, while the quick ratio is 2.

For the last year Zimmer Biomet Holdings, Inc., ZBH has seen a EPS growth of -81.50%. A performance for the year of 12.53%. The 52-week high is -2.77%, and the 52-week low is 36.27%. The average volume for Zimmer Biomet Holdings, Inc., ZBH is 500685.

With a target price of 127.68, can Zimmer Biomet Holdings, Inc., ZBH reach this target? Looking at the value indicators of Zimmer Biomet Holdings, Inc., ZBH. Zimmer Biomet Holdings, Inc. has a P/E of 484.66 and a forward P/E of 13.78. Perhaps the more useful indicator than P/E, is PEG which has a value of 43.47. Zimmer Biomet Holdings, Inc. also has a P/S and a P/B of 3.57 and 2.5 respectively. For P/cash, Zimmer Biomet Holdings, Inc. has a value of 23.9, while it is *TBA for P/free cash flow.

At the current price of 119.77, Zimmer Biomet Holdings, Inc. has a dividend yield of 0.80%. We see a return on equity of *TBA.

Looking more long-term Zimmer Biomet Holdings, Inc., is projected to get an EPS growth for the next five years of 11.15%. In the short-term an EPS growth of 9.97% in the next year is forecasted. This is after a EPS growth of -81.50% for this year and for the last five years a -23.60% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment